Construction of Semi-Supervised Spatial Projections to Identify the Source of Beta- and High Frequency Oscillations in Parkinson's Disease. - Luciano R. F. Branco; Ashwin Viswanathan; Arjun Tarakad; Nuri F. Ince (NER, 2023)

Enriched phenotypes in rare variant carriers suggest pathogenic mechanisms in rare disease patients. - Lane Fitzsimmons; Maria T. Acosta; David R. Adams; Ben Afzali; Ali Al-Beshri; Eric Allenspach; Aimee Allworth; Raquel L. Alvarez; Justin Alvey; Ashley Andrews; Euan A. Ashley; Carlos A. Bacino; et al. (BioData Min., 2025)

Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab. - Kirsten I. Taylor; Florian Lipsmeier; Marzia Antonella Scelsi; Ekaterina Volkova-Volkmar; Daria Rukina; Werner Popp; Stefan Lambrecht; Judith Anzures-Cabrera; David Summers; Markus Abt; Annabelle Monnet; Timothy Kilchenmann; et al. (npj Digit. Medicine, 2025)